Skip to main content
SpringerLink
Log in

Neuropsychologie des Ecstasy-Abusus

  • Chapter
Neuropsychologie psychischer Störungen

  • 14k Accesses

Zusammenfassung

Der Begriff Ecstasy wird meistens synonym für 3,4- Methylendioxymethamphetamin (MDMA) verwandt. MDMA ist die verbreiteteste Jugenddroge nach Cannabis und in der Regel auch der einzige Inhaltsstoff der Ecstasypillen. Nur gelegentlich werden chemische Analoga wie 3,4-Methylendioxyamphetamin und 3,4-Methylendioxyethylamphetamin, die hinsichtlich ihrer Wirkungen kaum vom MDMA zu unterscheiden sind, als Ecstasy verkauft. Deutlich seltener beinhalten die Ecstasypillen andere Substanzen wie Amphetaminstimulanzien, Koffein u. a. Vereinfachend werden im Folgenden die Begriffe Ecstasy und MDMA synonym verwandt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

15.4 Literatur

  • Azmitia EC (2007): Serotonin and brain: evolution, neuroplasticity, and homeostasis. Int Rev Neurobiol 77: 31–56.

    Article  PubMed  Google Scholar 

  • Bolla KI, McCann UD, Ricaurte GA (1998): Memory impairment in abstinent MDMA („Ecstasy“) users. Neurology 51: 1532–1537.

    PubMed  Google Scholar 

  • Buchert R, Thomasius R, Petersen K, Wilke F, Obrocki J, Nebeling B et al. (2006): Reversibility of ecstasy-induced reduction in serotonin transporter availability in polydrug ecstasy users. Eur J Nucl Med Mol Imaging 33: 188–199.

    Article  PubMed  Google Scholar 

  • Bzg A: Bundeszentrale für gesundheitliche Aufklärung (2001): Die Drogenaffinität Jugendlicher in der Bundesrepublik Deutschland 2001. Eine Wiederholungsbefragung der BZgA. Köln, Bundeszentrale für gesundheitliche Aufklärung

    Google Scholar 

  • Chang L, Ernst T, Grob CS, Poland RE (1999): Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, „ecstasy“) users. J Magn Reson Imaging 10: 521–526.

    Article  PubMed  Google Scholar 

  • Cowan RL, Lyoo IK, Sung SM, Ahn KH, Kim MJ, Hwang J et al. (2003): Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study. Drug Alcohol Depend 72: 225–235.

    Article  PubMed  Google Scholar 

  • Cowan RL (2007): Neuroimaging research in human MDMA users: a review. Psychopharmacology (Berl) 189: 539–556.

    Article  Google Scholar 

  • Curran HV, Verheyden SL (2003): Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function. Psychopharmacology (Berl) 169: 91–103.

    Article  Google Scholar 

  • Daumann J, Fimm B, Willmes K, Thron A, Gouzoulis-Mayfrank E (2003): Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study. Brain Res Cogn Brain Res 16: 479–487.

    Article  PubMed  Google Scholar 

  • Daumann J, Fischermann T, Pilatus U, Thron A, Moeller-Hartmann W, Gouzoulis-Mayfrank E (2004): Proton magnetic resonance spectroscopy in ecstasy (MDMA) users. Neurosci Lett 362: 113–116.

    Article  PubMed  Google Scholar 

  • Daumann J, Fischermann T, Heekeren K, Henke K, Thron A, Gouzoulis-Mayfrank E (2005): Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users. Psychopharmacology (Berl) 180: 607–611.

    Article  Google Scholar 

  • De Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, et al. (2008): Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study. J Psychopharmacol 22: 498–510.

    Article  PubMed  Google Scholar 

  • De Win MM, Jager G, Booij J et al. (2008a): Neurotoxic effects of ecstasy on the thalamus. Br J Psychiatry 193: 289–296.

    Article  PubMed  Google Scholar 

  • De Win MM, Jager G, Booij J et al. (2008b): Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brainal 131: 2936–2945.

    Article  Google Scholar 

  • Fischer C, Hatzidimitriou G, Wlos J, Katz J, Ricaurte G (1995): Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/−)3,4-methylenedioxymethamphetamine (MDMA, „ecstasy“). J Neurosci 15: 5476–5485.

    PubMed  Google Scholar 

  • Fisk JE, Montgomery C, Wareing M, Murphy PN (2006): The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic? Hum Psychopharmacol 21: 355–366.

    Article  PubMed  Google Scholar 

  • Fox HC, McLean A, Turner JJ, Parrott AC, Rogers R, Sahakian BJ (2002): Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA („ecstasy“) polydrug users. Psychopharmacology (Berl) 162: 203–214.

    Article  Google Scholar 

  • Gouzoulis-Mayfrank E, Thimm B, Rezk M, Hensen G, Daumann J (2003): Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Prog Neuropsychopharmacol Biol Psychiatry 27: 819–827.

    Article  PubMed  Google Scholar 

  • Gouzoulis-Mayfrank E, Fischermann T, Rezk M, Thimm B, Hensen G, Daumann J (2005): Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use. Drug Alcohol Depend 78: 317–323.

    Article  PubMed  Google Scholar 

  • Gouzoulis-Mayfrank E, Daumann J (2006a): Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage? Addiction 101: 348–361.

    Article  PubMed  Google Scholar 

  • Gouzoulis-Mayfrank E, Daumann J (2006b): The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview. J Psychopharmacol 20: 188–193.

    Article  PubMed  Google Scholar 

  • Gouzoulis-Mayfrank E, Daumann J (2009): Neurotoxicity of drugs of abuse — The case of methylenedioxyamphetamines (MDMA; ecstasy) and stimulant amphetamines. Dialogues in Clinical Neuroscience 11: 305–317.

    PubMed  Google Scholar 

  • Green AR, Mechan AO, Elliott JM, O’Shea E, Colado MI (2003): The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, „ecstasy“). Pharmacol Rev 55: 463–508.

    Article  PubMed  Google Scholar 

  • Hatzidimitriou G, McCann UD, Ricaurte GA (1999): Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/−)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 19: 5096–5107.

    PubMed  Google Scholar 

  • Jacobs BL, Azmitia EC (1992): Structure and function of the brain serotonin system. Physiol Rev 72: 165–229.

    PubMed  Google Scholar 

  • Jacobsen LK, Mencl WE, Pugh KR, Skudlarski P, Krystal JH (2004): Preliminary evidence of hippocampal dysfunction in adolescent MDMA („ecstasy“) users: possible relationship to neurotoxic effects. Psychopharmacology (Berl) 173: 383–390.

    Article  Google Scholar 

  • Kalechstein AD, De La GR, Mahoney JJ, III, Fantegrossi WE, Newton TF (2007): MDMA use and neurocognition: a meta-analytic review. Psychopharmacology (Berl) 189: 531–537.

    Article  Google Scholar 

  • Lundqvist T (2005): Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol Biochem Behav 81: 319–330.

    Article  PubMed  Google Scholar 

  • Lyvers M (2006): Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues. Drug Alcohol Rev 25: 269–276.

    Article  PubMed  Google Scholar 

  • Morgan MJ (1998): Recreational use of „ecstasy“ (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19: 252–264.

    Article  PubMed  Google Scholar 

  • Morgan MJ, McFie L, Fleetwood H, Robinson JA (2002): Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? Psychopharmacology (Berl) 159: 294–303.

    Article  Google Scholar 

  • Morgan MJ, Impallomeni LC, Pirona A, Rogers RD (2006): Elevated Impulsivity and Impaired Decision-Making in Abstinent Ecstasy (MDMA) Users Compared to Polydrug and Drug-Naive Controls. Neuropsychopharmacology 31: 1562–1573.

    Article  PubMed  Google Scholar 

  • Quednow BB, Jessen F, Kuhn KU, Maier W, Daum I, Wagner M (2006a): Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction. J Psychopharmacol 20: 373–384.

    Article  PubMed  Google Scholar 

  • Quednow BB, Kuhn KU, Hoppe C, Westheide J, Maier W, Daum I et al. (2006b): Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA („Ecstasy“). Psychopharmacology (Berl): 1–14.

    Google Scholar 

  • Reneman L, Majoie CB, Schmand B, van Den BW, den Heeten GJ (2001): Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report. Biol Psychiatry 50: 550–554.

    Article  PubMed  Google Scholar 

  • Reneman L, Majoie CB, Flick H, den Heeten GJ (2002): Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results. AJNR Am J Neuroradiol 23: 231–237.

    PubMed  Google Scholar 

  • Reneman L, Schilt T, de Win MM, Booij J, Schmand B, van Den BW et al. (2006): Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. J Psychopharmacol 20: 389–399.

    Article  PubMed  Google Scholar 

  • Ricaurte GA, Martello AL, Katz JL, Martello MB (1992): Lasting effects of (+−)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. J Pharmacol Exp Ther 261: 616–622.

    PubMed  Google Scholar 

  • Roiser JP, Rogers R, Sahakian BJ (2007): Neuropsychological function in ecstasy users: a study controlling for polydrug use. Psychopharmacology (Berl) 189: 505–516.

    Article  Google Scholar 

  • Schilt T, de Win MM, Koeter M et al. (2007): Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Arch Gen Psychiatry 64: 728–736.

    Article  PubMed  Google Scholar 

  • Thomasius R, Petersen K, Buchert R, Andresen B, Zapletalova P, Wartberg L et al. (2003): Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology (Berl) 167: 85–96.

    Google Scholar 

  • Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L et al. (2006): Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. J Psychopharmacol 20: 211–225.

    Article  PubMed  Google Scholar 

  • Ward J, Hall K, Haslam C (2006): Patterns of memory dysfunction in current and 2-year abstinent MDMA users. J Clin Exp Neuropsychol 28: 306–324.

    Article  PubMed  Google Scholar 

  • Wareing M, Fisk JE, Murphy PN (2000): Working memory deficits in current and previous users of MDMA (‚ecstasy‘). Br J Psychol 91 (Pt 2): 181–188.

    Article  PubMed  Google Scholar 

  • Wareing M, Fisk JE, Murphy P, Montgomery C (2004): Verbal working memory deficits in current and previous users of MDMA. Hum Psychopharmacol 19: 225–234.

    Article  PubMed  Google Scholar 

  • Wareing M, Fisk JE, Murphy P, Montgomery C (2005): Visuo-spatial working memory deficits in current and former users of MDMA (‘ecstasy’). Hum Psychopharmacol 20: 115–123.

    Article  PubMed  Google Scholar 

  • Zakzanis KK, Young DA (2001): Memory impairment in abstinent MDMA („Ecstasy“) users: a longitudinal investigation. Neurology 56: 966–969.

    PubMed  Google Scholar 

  • Zakzanis KK, Campbell Z (2006): Memory impairment in now abstinent MDMA users and continued users: a longitudinal follow-up. Neurology 66: 740–741.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Allgemeine Psychiatrie, LRV-Klinik, Wilhelm-Griesinger-Str. 23, 51109, Köln

    Prof. Dr. Euphrosyne Gouzoulis-Mayfrank

  2. Zentrum für Neurologie und Psychiatrie Arbeitsgruppe Experimentelle Psychiatrie, Uniklinik Köln, Kerpener Str. 62, 50937, Köln

    PD Dr. Joerg Daumann

Authors
  1. Prof. Dr. Euphrosyne Gouzoulis-Mayfrank
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. PD Dr. Joerg Daumann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lehrstuhl für Physiologische Psychologie, Otto-Friedrich-Universität Bamberg, Markusplatz 3, 96045, Bamberg

    Stefan Lautenbacher

  2. Institut für Medizinische Psychologie und Soziologie, RWTH Aachen, Pauwelsstraße 30, 52074, Aachen

    Siegfried Gauggel

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Gouzoulis-Mayfrank, E., Daumann, J. (2010). Neuropsychologie des Ecstasy-Abusus. In: Lautenbacher, S., Gauggel, S. (eds) Neuropsychologie psychischer Störungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-72340-0_15

Download citation

Publish with us

Policies and ethics

Search

Navigation